Cargando…

Primary systemic therapy for operable breast cancer.

Eighty-eight patients presenting with operable breast cancer of 4 cm or greater in diameter (T2, T3, N0, N1, M0) have received primary systemic therapy. Response was assessed following 12 weeks of systemic therapy by linear regression analysis of changes in tumour volume. Definitive locoregional sur...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderson, E. D., Forrest, A. P., Hawkins, R. A., Anderson, T. J., Leonard, R. C., Chetty, U.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1991
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1972365/ https://www.ncbi.nlm.nih.gov/pubmed/1827031

Ejemplares similares

Primary systemic therapy for operable breast cancer--10-year survival data after chemotherapy and hormone therapy.
por: Cameron, D. A., et al.
Publicado: (1997)

Response to endocrine manipulation and oestrogen receptor concentration in large operable primary breast cancer.
por: Anderson, E. D., et al.
Publicado: (1989)

Does the oestrogen receptor concentration of a breast cancer change during systemic therapy?
por: Hawkins, R. A., et al.
Publicado: (1990)

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy.
por: Hawkins, R. A., et al.
Publicado: (1988)

pS2 is an independent factor of good prognosis in primary breast cancer.
por: Thompson, A. M., et al.
Publicado: (1993)

Randomised comparison of 5 years of adjuvant tamoxifen with continuous therapy for operable breast cancer. The Scottish Cancer Trials Breast Group.
por: Stewart, H. J., et al.
Publicado: (1996)

High-dose chemotherapy supported by peripheral blood progenitor cells in poor prognosis metastatic breast cancer--phase I/II study. Edinburgh Breast Group.
por: Cameron, D. A., et al.
Publicado: (1996)

Prospective evaluation of prognostic factors in operable breast cancer.
por: Hawkins, R. A., et al.
Publicado: (1996)

p53 gene mRNA expression and chromosome 17p allele loss in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1990)

Partial deletion of chromosome 11p in breast cancer correlates with size of primary tumour and oestrogen receptor level.
por: Mackay, J., et al.
Publicado: (1988)

Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
por: Hubbard, A. L., et al.
Publicado: (1994)

PS2 mRNA expression adds prognostic information to node status for 6-year survival in breast cancer.
por: Thompson, A. M., et al.
Publicado: (1998)

Oestrogen receptors and the response to endocrine therapy in advanced breast cancer.
por: Roberts, M. M., et al.
Publicado: (1978)

Identification of long-term survivors in primary breast cancer by dynamic modelling of tumour response
por: Cameron, D A, et al.
Publicado: (2000)

Outcome after extended follow-up in a prospective study of operable breast cancer: key factors and a prognostic index
por: Hawkins, R A, et al.
Publicado: (2002)

Locally advanced breast cancer: report of phase II study and subsequent phase III trial.
por: Rodger, A., et al.
Publicado: (1992)

Epidermal growth factor receptors in intracranial and breast tumours: their clinical significance.
por: Hawkins, R. A., et al.
Publicado: (1991)

Comparative pathology of breast cancer in a randomised trial of screening.
por: Anderson, T. J., et al.
Publicado: (1991)

The relevance of control histology in oestrogen receptor estimation.
por: Steele, R. J., et al.
Publicado: (1987)

The Examination of the Blood in Cases of Cancer of the Breast in Regard to Operation and Prognosis
por: Anderson, Ellen Davidson
Publicado: (1921)

The Examination of the Blood in Cases of Cancer of the Breast in Regard to Operation and Prognosis
por: Anderson, Ellen Davidson
Publicado: (1921)

Reproducibility of measurements of oestrogen-receptor concentration in breast cancer.
por: Hawkins, R. A., et al.
Publicado: (1977)

Cyclic AMP binding proteins and prognosis in breast cancer.
por: Miller, W. R., et al.
Publicado: (1990)

Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2007)

The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer
por: Al Murri, A M, et al.
Publicado: (2004)

Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer
por: Damera, A, et al.
Publicado: (2003)

Mathematical modelling of tumour response in primary breast cancer.
por: Cameron, D. A., et al.
Publicado: (1996)

A prognostic index for operable, node-negative breast cancer
por: McCallum, M, et al.
Publicado: (2004)

Primary Endocrine Therapy in Older Women with Breast Cancer
por: Pepping, R. M. C., et al.
Publicado: (2017)

Antitumour and biological effects of letrozole and GnRH analogue as primary therapy in premenopausal women with ER and PgR positive locally advanced operable breast cancer
por: Torrisi, R, et al.
Publicado: (2007)

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer
por: Anderson, R.A., et al.
Publicado: (2017)

DNA analysis of breast tumour fine needle aspirates using flow cytometry.
por: Levack, P. A., et al.
Publicado: (1987)

Photodynamic Therapy in Primary Breast Cancer
por: Banerjee, Shramana M., et al.
Publicado: (2020)

Improving systemic breast cancer therapy: time to look beyond the primary tumour?
por: Vandendriessche, E, et al.
Publicado: (2015)

Cervical intraepithelial neoplasia in patients with breast cancer: a cytological and colposcopic study.
por: Hughes, R. G., et al.
Publicado: (1993)

Breast Volumes in Cancer of the Breast
por: Katariya, R. N., et al.
Publicado: (1974)

Effect of neoadjuvant treatment with anastrozole on tumour histology in postmenopausal women with large operable breast cancer
por: Anderson, T J, et al.
Publicado: (2002)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

Primary chemotherapy for operable breast cancer: the NSABP experience
por: Bear, HD
Publicado: (2005)

Diagnostic Accuracy of MRI in Evaluating Response After Neoadjuvant Systemic Therapy in Operable Breast Cancer
por: Khazindar, Abdullah R, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_bt1f18ao9tj4rm62plmhu84tdj